High-dose therapy and autologous bone marrow transplantation for hodgkin's disease patients with relapses potentially treatable by radical radiation therapy
- 30 August 1995
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 33 (1) , 189-194
- https://doi.org/10.1016/0360-3016(95)00117-h
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.Journal of Clinical Oncology, 1993
- Prognostic factors for patients with hodgkin disease in first relapseCancer, 1993
- High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant.Journal of Clinical Oncology, 1993
- The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight- year study of 155 patientsBlood, 1993
- High-dose chemotherapy and autologous bone marrow transplantation for relapsed and refractory Hodgkin's diseaseEuropean Journal Of Cancer, 1992
- Autologous bone marrow transplantation for patients with relapsed hodgkin's diseaseThe American Journal of Medicine, 1991
- Primary and salvage chemotherapy in advanced Hodgkin's disease: The Milan Cancer Institute experienceAnnals of Oncology, 1991
- High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.Journal of Clinical Oncology, 1990
- Treatment of refractory and relapsed Hodgkin's disease: Intensive chemotherapy and autologous bone marrow or peripheral blood stem cell supportMedical and Pediatric Oncology, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958